Dudediligence.

Arcturus Therapeutics Holdings Inc

ARCTNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Regulation FD disclosureSep 23 →InsidersNo open-market buys or sales.→HoldersFederated Hermes 11.6%ARK 10.2%BlackRock 9.2%→Financing →PeersClosest companies: MRNA, VIR, IBRX→

From the filings

Figures

Revenue
$29.4Mlast 12 months
Net income
−$93.3Mlast 12 months
Operating cash flow
−$58.6Mlast 12 months
Cash and equivalents
$191.5Mat the last balance sheet
Shares outstanding
28.4M shareson issue
Every year and quarter →